CN108159380A - Renal function conditioning medication perfume and its processing technology - Google Patents
Renal function conditioning medication perfume and its processing technology Download PDFInfo
- Publication number
- CN108159380A CN108159380A CN201810111217.8A CN201810111217A CN108159380A CN 108159380 A CN108159380 A CN 108159380A CN 201810111217 A CN201810111217 A CN 201810111217A CN 108159380 A CN108159380 A CN 108159380A
- Authority
- CN
- China
- Prior art keywords
- powder
- incense drug
- cortex eucommiae
- cassia twig
- fragrant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 222
- 229940079593 drug Drugs 0.000 title claims abstract description 195
- 239000002304 perfume Substances 0.000 title claims abstract description 50
- 230000003907 kidney function Effects 0.000 title claims abstract description 47
- 230000003750 conditioning effect Effects 0.000 title claims abstract description 38
- 238000005516 engineering process Methods 0.000 title claims description 20
- 238000012545 processing Methods 0.000 title claims description 18
- 239000000843 powder Substances 0.000 claims abstract description 131
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 74
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 74
- 239000002994 raw material Substances 0.000 claims abstract description 74
- 239000000463 material Substances 0.000 claims abstract description 58
- OEYQBKYISMRWQB-UHFFFAOYSA-N Santal Chemical compound C=1C(OC)=CC(O)=C(C2=O)C=1OC=C2C1=CC=C(O)C(O)=C1 OEYQBKYISMRWQB-UHFFFAOYSA-N 0.000 claims abstract description 42
- 244000020518 Carthamus tinctorius Species 0.000 claims abstract description 28
- 244000223014 Syzygium aromaticum Species 0.000 claims abstract description 28
- 235000016639 Syzygium aromaticum Nutrition 0.000 claims abstract description 28
- 235000003255 Carthamus tinctorius Nutrition 0.000 claims abstract description 27
- 240000000513 Santalum album Species 0.000 claims abstract description 27
- 239000011148 porous material Substances 0.000 claims abstract description 27
- 244000061520 Angelica archangelica Species 0.000 claims abstract description 26
- 235000001287 Guettarda speciosa Nutrition 0.000 claims abstract description 26
- 240000001341 Reynoutria japonica Species 0.000 claims abstract description 26
- 235000018167 Reynoutria japonica Nutrition 0.000 claims abstract description 26
- 235000008632 Santalum album Nutrition 0.000 claims abstract description 26
- 241000219784 Sophora Species 0.000 claims abstract description 26
- 210000000582 semen Anatomy 0.000 claims abstract description 26
- 241001106462 Ulmus Species 0.000 claims abstract description 25
- 244000197580 Poria cocos Species 0.000 claims abstract description 24
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 24
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 24
- 244000241872 Lycium chinense Species 0.000 claims abstract description 23
- 235000015468 Lycium chinense Nutrition 0.000 claims abstract description 23
- 241000271309 Aquilaria crassna Species 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 67
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 51
- 241001122767 Theaceae Species 0.000 claims description 48
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 42
- 238000002156 mixing Methods 0.000 claims description 34
- 239000007788 liquid Substances 0.000 claims description 29
- 238000001035 drying Methods 0.000 claims description 27
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims description 26
- 235000017491 Bambusa tulda Nutrition 0.000 claims description 26
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims description 26
- 239000011425 bamboo Substances 0.000 claims description 26
- 238000004806 packaging method and process Methods 0.000 claims description 26
- 235000012907 honey Nutrition 0.000 claims description 23
- 239000011812 mixed powder Substances 0.000 claims description 19
- 238000009835 boiling Methods 0.000 claims description 17
- 239000000376 reactant Substances 0.000 claims description 17
- 230000001954 sterilising effect Effects 0.000 claims description 17
- 238000011282 treatment Methods 0.000 claims description 17
- 102000004190 Enzymes Human genes 0.000 claims description 15
- 108090000790 Enzymes Proteins 0.000 claims description 15
- 238000004659 sterilization and disinfection Methods 0.000 claims description 13
- 239000004382 Amylase Substances 0.000 claims description 11
- 102000013142 Amylases Human genes 0.000 claims description 11
- 108010065511 Amylases Proteins 0.000 claims description 11
- 235000019418 amylase Nutrition 0.000 claims description 11
- 230000009849 deactivation Effects 0.000 claims description 10
- 239000008367 deionised water Substances 0.000 claims description 10
- 229910021641 deionized water Inorganic materials 0.000 claims description 10
- 239000012141 concentrate Substances 0.000 claims description 9
- 238000000855 fermentation Methods 0.000 claims description 9
- 230000004151 fermentation Effects 0.000 claims description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 238000006243 chemical reaction Methods 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 239000012530 fluid Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- 239000008223 sterile water Substances 0.000 claims description 7
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 6
- 239000012153 distilled water Substances 0.000 claims description 6
- 239000012528 membrane Substances 0.000 claims description 6
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims description 5
- 244000241838 Lycium barbarum Species 0.000 claims description 5
- 235000001014 amino acid Nutrition 0.000 claims description 5
- 229940024606 amino acid Drugs 0.000 claims description 5
- 150000001413 amino acids Chemical class 0.000 claims description 5
- 235000013922 glutamic acid Nutrition 0.000 claims description 5
- 239000004220 glutamic acid Substances 0.000 claims description 5
- 238000001223 reverse osmosis Methods 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 235000015459 Lycium barbarum Nutrition 0.000 claims description 4
- 235000019441 ethanol Nutrition 0.000 claims description 4
- 239000002023 wood Substances 0.000 claims description 3
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- 235000003704 aspartic acid Nutrition 0.000 claims description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 235000002374 tyrosine Nutrition 0.000 claims description 2
- 238000001291 vacuum drying Methods 0.000 claims description 2
- 244000082204 Phyllostachys viridis Species 0.000 claims 6
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 244000018795 Prunus mume Species 0.000 claims 1
- 235000011158 Prunus mume Nutrition 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 230000004913 activation Effects 0.000 claims 1
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 239000004744 fabric Substances 0.000 claims 1
- 235000013599 spices Nutrition 0.000 abstract description 14
- 235000009508 confectionery Nutrition 0.000 abstract description 6
- 230000007794 irritation Effects 0.000 abstract description 4
- 239000008280 blood Substances 0.000 abstract description 3
- 239000002699 waste material Substances 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 2
- 210000001835 viscera Anatomy 0.000 abstract description 2
- 244000269722 Thea sinensis Species 0.000 abstract 2
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 43
- 241001330002 Bambuseae Species 0.000 description 20
- 238000000859 sublimation Methods 0.000 description 13
- 230000008022 sublimation Effects 0.000 description 13
- 230000000694 effects Effects 0.000 description 10
- 238000007710 freezing Methods 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000001647 Renal Insufficiency Diseases 0.000 description 7
- 201000006370 kidney failure Diseases 0.000 description 7
- 235000019082 Osmanthus Nutrition 0.000 description 6
- 241000333181 Osmanthus Species 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 235000015110 jellies Nutrition 0.000 description 5
- 239000008274 jelly Substances 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 4
- 208000020832 chronic kidney disease Diseases 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 239000007789 gas Substances 0.000 description 4
- 210000003127 knee Anatomy 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000037157 Azotemia Diseases 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 3
- UGFAIRIUMAVXCW-UHFFFAOYSA-N Carbon monoxide Chemical compound [O+]#[C-] UGFAIRIUMAVXCW-UHFFFAOYSA-N 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 241001251949 Xanthium sibiricum Species 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 208000022831 chronic renal failure syndrome Diseases 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 208000009304 Acute Kidney Injury Diseases 0.000 description 2
- 241000271307 Aquilaria malaccensis Species 0.000 description 2
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 2
- 244000192528 Chrysanthemum parthenium Species 0.000 description 2
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 208000033626 Renal failure acute Diseases 0.000 description 2
- 241000576755 Sclerotia Species 0.000 description 2
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 2
- 201000011040 acute kidney failure Diseases 0.000 description 2
- 208000012998 acute renal failure Diseases 0.000 description 2
- 230000004596 appetite loss Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 241001233957 eudicotyledons Species 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- 235000008384 feverfew Nutrition 0.000 description 2
- 239000003546 flue gas Substances 0.000 description 2
- 230000008014 freezing Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 208000019017 loss of appetite Diseases 0.000 description 2
- 235000021266 loss of appetite Nutrition 0.000 description 2
- 230000031864 metaphase Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 208000013220 shortness of breath Diseases 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 208000009852 uremia Diseases 0.000 description 2
- 210000002700 urine Anatomy 0.000 description 2
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 241000213006 Angelica dahurica Species 0.000 description 1
- 241000132012 Atractylodes Species 0.000 description 1
- 241000092665 Atractylodes macrocephala Species 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 244000080208 Canella winterana Species 0.000 description 1
- 235000008499 Canella winterana Nutrition 0.000 description 1
- 241000522254 Cassia Species 0.000 description 1
- 235000021511 Cinnamomum cassia Nutrition 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000110637 Cuscuta chinensis Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010061818 Disease progression Diseases 0.000 description 1
- 241000208686 Eucommiaceae Species 0.000 description 1
- 241000266331 Eugenia Species 0.000 description 1
- 241001289522 Fallopia Species 0.000 description 1
- 241001289529 Fallopia multiflora Species 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 235000002710 Ilex cornuta Nutrition 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 241000790228 Nardostachys jatamansi Species 0.000 description 1
- 241000588278 Osmanthus heterophyllus Species 0.000 description 1
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 1
- 244000148137 Patrinia villosa Species 0.000 description 1
- 235000019109 Patrinia villosa Nutrition 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 241000222640 Polyporus Species 0.000 description 1
- 244000171085 Polyporus umbellatus Species 0.000 description 1
- 235000004837 Polyporus umbellatus Nutrition 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 240000008199 Rhododendron molle Species 0.000 description 1
- 244000046101 Sophora japonica Species 0.000 description 1
- 235000010586 Sophora japonica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241001601725 Sthenias Species 0.000 description 1
- 241001062472 Stokellia anisodon Species 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 241001619444 Wolfiporia cocos Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000008033 biological extinction Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 238000002485 combustion reaction Methods 0.000 description 1
- 230000001447 compensatory effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000000502 dialysis Methods 0.000 description 1
- 230000005750 disease progression Effects 0.000 description 1
- 238000004821 distillation Methods 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000008717 functional decline Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 239000004519 grease Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 208000018706 hematopoietic system disease Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940125698 hormone suppressant Drugs 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000007365 immunoregulation Effects 0.000 description 1
- 229960003444 immunosuppressant agent Drugs 0.000 description 1
- 230000001861 immunosuppressant effect Effects 0.000 description 1
- 239000003018 immunosuppressive agent Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 230000004199 lung function Effects 0.000 description 1
- 238000013160 medical therapy Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- WASNIKZYIWZQIP-AWEZNQCLSA-N nerolidol Natural products CC(=CCCC(=CCC[C@@H](O)C=C)C)C WASNIKZYIWZQIP-AWEZNQCLSA-N 0.000 description 1
- 150000002098 nerolidol derivatives Chemical class 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000012109 statistical procedure Methods 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 210000004916 vomit Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
- 239000001841 zingiber officinale Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/286—Carthamus (distaff thistle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/43—Cuscutaceae (Dodder family), e.g. Cuscuta epithymum or greater dodder
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/46—Eucommiaceae (Eucommia family), e.g. hardy rubber tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
- A61K36/704—Polygonum, e.g. knotweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/83—Thymelaeaceae (Mezereum family), e.g. leatherwood or false ohelo
- A61K36/835—Aquilaria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/84—Valerianaceae (Valerian family), e.g. valerian
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Botany (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Pulmonology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of renal function conditioning medication perfume, are prepared including following raw material：2~5wt% of fir powder, 0.4~2wt% of nanmu powder, 1~3wt% of elm bark powder, additivity 1~3wt% of material, surplus is incense drug；The incense drug includes the fruit of Chinese wolfberry, Cortex Eucommiae, Rhizoma Atractylodis Macrocephalae, cassia twig, sophora flower, rhizoma zingiberis, Semen Cuscutae, safflower, the fleece-flower root, Poria cocos, umbellate pore furgus, agalloch eaglewood either Ligaloes tea, santal or sandalwood tea, rhizoma nardostachyos, the root of Dahurain angelica, cloves.It is more that renal function conditioning medication perfume (or spice) of the present invention solves the fragrant miscellaneous gas of prior art medicine, the problem of irritation is strong, assign the sucking sense of the fragrant fresh and sweet soft exquisiteness of medicine, after patient's smelling, the discharge conduit dredging of body, local internal organs qi-blood circulating accelerates, and the channels and collaterals of whole body are got through, and the waste of metabolism can exclude.
Description
Technical field
The present invention relates to medicine perfume (or spice) technical field, more particularly to renal function conditioning medication perfume and its processing technology.
Background technology
Doctor trained in Western medicine thinks, kidney is secretion urine, discharged waste, poisonous substance vitals, it is dense to play adjusting human electrolyte
Degree, the effect for maintaining acid-base balance.Impaired renal function or gradually decline, the excretion of kidney and immunoregulation function will also reduce.Kidney function
Can damage it is serious when, it also occur that uremia and jeopardize life.Renal function can gradually fail, but live as the age increases
In, some undesirable living habits or behavior will also tend to the major reason as kidney function damage.
Renal failure is divided into acute and chronic two kinds by the suddenly slow of its breaking-out.Acute renal failure system is because of a variety of diseases
Two kidneys is caused to lose excretory function, abbreviation acute renal failure in a short time.Chronic renal failure is caused by the various causes of disease
The comprehensive card for one group of clinical symptoms composition that chronic kidney disease is developed to late period and occurs.It will be chronic according to the degree of kidney function damage
Renal failure was divided into for 4 phases：1. kidney Reserved function declines, patient is asymptomatic.2. compensatory stage of renal insufficiency.3. renal function loses generation
It repays the phase (azotemia phase), patient has weak, loss of appetite and anaemia.4. uremic phase has symptoms of uremia.
Modern medical therapy early metaphase renal failure mainly coordinates necessary amino acid, control by diet control at present
The measures such as blood pressure, reduction blood glucose, reduction Urine proteins achieve the purpose that protect renal function.But these treatments can only delaying chronic kidney hypofunction
The disease progression exhausted, it is impossible to tackle the problem at its root.And treatment cycle is long, and patient easily generates conflict over the course for the treatment of
Psychology.Therefore, any therapy that can delay renal function kidney failure all has great importance, this has become domestic and international ten
Divide the problem paid attention to.
Confirmed by clinical practice for many years and experimental study, traditional Chinese medicine protection renal function, improve clinical symptoms and
Delay have comparable advantage in terms of early metaphase chronic renal failure progress.The traditional Chinese medical science thinks renal failure for mixture of asthenia and sthenia, by void
It causes real, finally makes that sb.'s illness took a turn for the worse, therefore active intervention is answered in renal failure early stage.
Invention content
The present invention seeks to what is be achieved by following technical solution.
It is fragrant that the technical problems to be solved by the invention are to provide a kind of renal function conditioning medication.
The invention discloses a kind of renal function conditioning medication perfume, are prepared including following raw material：2~5wt% of fir powder,
0.4~2wt% of nanmu powder, 1~3wt% of elm bark powder, additivity 1~3wt% of material, surplus is incense drug；The incense drug includes Chinese holly
Matrimony vine, Cortex Eucommiae, Rhizoma Atractylodis Macrocephalae, cassia twig, sophora flower, rhizoma zingiberis, Semen Cuscutae, safflower, the fleece-flower root, Poria cocos, umbellate pore furgus, agalloch eaglewood or Ligaloes tea, wingceltis
Fragrant or sandalwood tea, rhizoma nardostachyos, the root of Dahurain angelica, cloves.
Specifically, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae, 1~3g of Rhizoma Atractylodis Macrocephalae, 1~3g of cassia twig,
1~3g of sophora flower, it 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, 3~4g of Poria cocos, 1~3g of umbellate pore furgus, sinks
Fragrant either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, 0.1~1g of the root of Dahurain angelica, 0.5~1g of cloves.
The additivity material is the mixture of one or more of petal, smoked plum extractive, honey reactant.It is preferred that
Ground, the additivity material are smoked plum extractive and the mixture of honey reactant, wherein smoked plum extractive and honey reactant
Mass ratio be 1：1.
Containing a large amount of organic acid, phenols and Ester in dark plum, have and adjust flue gas pH, improve stimulation, it is soft
With the effect of flue gas.And honey reactant has good inhibition and cover effect to irritation and cigarettes, wines and miscellaneous goods gas.
The preparation method of the smoked plum extractive is：By the dark plum of naturally dry, after crushed 40~60 mesh sieve, with feed liquid
Than 1：(10~20) (g/mL) is added in the ethyl alcohol of volume fraction 95%, is extracted 2~5 hours in 70~80 DEG C, is obtained extracting solution；
After extracting solution is centrifuged 10~15 minutes with 4000~5000 revs/min, supernatant liquor is taken；By supernatant liquor in temperature 20~65
DEG C, concentrated using reverse osmosis membrane under conditions of 20~35 standard atmospheric pressure of pressure, 2~3m/s of flow velocity, obtain concentrate；It will concentration
Liquid vacuum freeze drying obtains the smoked plum extractive.
The preparation process of the honey reactant is：0.3~0.5g amino acid and 1~2g honey are uniformly mixed, added in
10~15mL propylene glycol is heated to 110~120 DEG C and reacts 2~3 hours；After reaction, reaction solution is cooled to 20~30
DEG C, vacuum drying obtains the honey reactant.
The amino acid is one or more of tyrosine, valine, aspartic acid, asparagine acid, glutamic acid
Mixture.
The second technical problem to be solved by the present invention is to provide a kind of processing technology of renal function conditioning medication perfume.
The present invention discloses a kind of processing technology of renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae,
1~3g of Rhizoma Atractylodis Macrocephalae, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, Fu
3~4g of Siberian cocklebur, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, the root of Dahurain angelica 0.1
~1g, 0.5~1g of cloves；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80~100 are crushed
Sieve, obtains mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80~100 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, osmanthus
Branch powder and mixed powder mixing, obtain incense drug；
(3) and expect：Incense drug, fir powder, nanmu powder, elm bark powder, additivity material are put into blender, according to incense drug with
Water weight ratio 1：The ratio of (1~1.5) adds in 40~50 DEG C of water, is stirred 20~30 minutes with 20~40 revs/min；
(4) it is molded：Material after step (3) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(5) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(6) packaging is stored sth. in a cellar：After the fragrant item packaging after drying, in the ring of 15~20 DEG C of temperature, relative humidity 70~80%
Store sth. in a cellar in border 7~60 days.
Due to containing starch and cell wall class substance in the eucaryotic cell structure of Chinese medicine material, medicine perfume (or spice) is caused to have in combustion
Effect ingredient cannot discharge and generate the miscellaneous gas of irritation, this can influence the quality of medicine perfume (or spice) fragrance and user's smelling, therefore, pass through by
Chinese medicine material enzymolysis after grinding improves the flavouring essence quality of medicine perfume.
Invention additionally discloses a kind of processing technologys of renal function conditioning medication perfume, include the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae,
1~3g of Rhizoma Atractylodis Macrocephalae, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, Fu
3~4g of Siberian cocklebur, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, the root of Dahurain angelica 0.1
~1g, 0.5~1g of cloves；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80~100 are crushed
Sieve, obtains mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80~100 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, osmanthus
Branch powder and mixed powder mixing, obtain incense drug；
(3) it digests：30~50g of incense drug of step (2) is weighed, 140~200mL of deionized water is added in, sequentially adds incense drug
The pectase and the amylase of 0.001~0.003 times of incense drug weight that 0.001~0.003 times of weight are uniformly mixed, in 40~45
DEG C enzymolysis 2~3 hours；The enzyme deactivation 5~after ten minutes in boiling water bath, vacuum freeze drying, the perfume (or spice) after being digested by enzymolysis liquid
Medicine；
(4) and expect：By after enzymolysis incense drug, fir powder, nanmu powder, elm bark powder, additivity material be put into blender, press
According to the incense drug after enzymolysis and water weight ratio 1：The ratio of (1~1.5) adds in 40~50 DEG C of water, with 20~40 revs/min of stirrings
20~30 minutes；
(5) it is molded：Material after step (4) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(6) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(7) packaging is stored sth. in a cellar：After the fragrant item packaging after drying, in the ring of 15~20 DEG C of temperature, relative humidity 70~80%
Store sth. in a cellar in border 7~60 days.
By cellulose, pectin, the protein in the method degradation incense drug raw material of microbial fermentation, regulation and control medicine perfume (or spice) generates
Flue gas forms.Meanwhile the technique effect smelt perfume (or spice), play flavouring of medicine perfume can be improved by fermentation.
Preferably, the processing technology of renal function conditioning medication perfume of the present invention, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae,
1~3g of Rhizoma Atractylodis Macrocephalae, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, Fu
3~4g of Siberian cocklebur, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, the root of Dahurain angelica 0.1
~1g, 0.5~1g of cloves；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80~100 are crushed
Sieve, obtains mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80~100 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, osmanthus
Branch powder and mixed powder mixing, obtain incense drug；
(3) it digests：30~50g of incense drug of step (2) is weighed, 140~200mL of deionized water is added in, sequentially adds incense drug
The pectase and the amylase of 0.001~0.003 times of incense drug weight that 0.001~0.003 times of weight are uniformly mixed, in 40~45
DEG C enzymolysis 2~3 hours；The enzyme deactivation 5~after ten minutes in boiling water bath, vacuum freeze drying, the perfume (or spice) after being digested by enzymolysis liquid
Medicine；
(4) yeast ferments：10~20g of yeast is added in the sterile water of 35~40 DEG C of 100~150mL temperature, in 30~
32 DEG C activate 1~2 hour, obtain activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：(10~12) (g/mL) adds in distillation
Water, in boiling water bath sterilization treatment 20~30 minutes；Mixed liquor after sterilizing is cooled to 30~35 DEG C, adds in mixeding liquid volume
0.03~0.06 activated yeast ferments 30~48 hours under conditions of 30~35 DEG C, pH5~6；By zymotic fluid vacuum refrigeration
It is dry, obtain the incense drug after yeast fermentation；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, additivity material are put into blender
In, incense drug and water weight ratio 1 after fermenting according to yeast：The ratio of (1~1.5) adds in 40~50 DEG C of water, with 20~40 turns/
Minute stirring 20~30 minutes；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：After the fragrant item packaging after drying, in the ring of 15~20 DEG C of temperature, relative humidity 70~80%
Store sth. in a cellar in border 7~60 days.
Sandalwood tea described in raw material of the present invention not only may be used commercially available sandalwood tea, but also can make by oneself, such as referenced patent
The specific embodiment of the patent of invention of application number 201010154391.4 prepares sandalwood tea.
Ligaloes tea described in raw material of the present invention not only may be used commercially available Ligaloes tea, but also can make by oneself, such as referenced patent
The embodiment one of the patent of invention of application number 201210061883.8 prepares Ligaloes tea.
Incense drug generally use agalloch eaglewood and santal of the prior art are used directly to system perfume, but their fire is larger, people
It inhales and easily gets angry, and the fragrance of agalloch eaglewood and santal easily leaks during crushing and mixing after hearing.It is attempted in the present invention
Agalloch eaglewood and santal are replaced using Ligaloes tea and sandalwood tea.Ligaloes tea and sandalwood tea do not remove only original compared to agalloch eaglewood and santal
The internal heat of material, fragrance is not easy outward leakage, but also containing substances such as benzyl carbinol, linalool, nerolidols, is more suitable for being added to
It is used in medicine perfume (or spice).
Renal function conditioning medication perfume (or spice) of the present invention solves the problem of fragrant miscellaneous gas of prior art medicine is more, and irritation is strong, assigns
Give the sucking sense of fragrant fresh and sweet soft exquisiteness of medicine, after patient's smelling, the discharge conduit of body is dredged, and local internal organs qi-blood circulating adds
Speed, the channels and collaterals of whole body are got through, and the waste of metabolism can exclude.
Specific embodiment
It is further illustrated the present invention below by the mode of embodiment, but does not therefore limit the present invention to the reality
It applies among a range.Test method without specific conditions in the following example, according to conventional methods and conditions or according to quotient
Product specification selects.
In following embodiments,
Shirt wood powder, using cloud shirt wood, purchased from Lingshou County Hong Ren mineral products processings factory, 100 mesh of grain size.
Nanmu powder, using silkwood, purchased from wooden gal sieve trade (Xiamen) Co., Ltd, 100 mesh of grain size.
Elm bark powder is crushed using the dry bark of yellow elm.Purchased from Xi'an Lv Quan Science and Technology Ltd.s, grain size 100
Mesh.
The fruit of Chinese wolfberry, Classification system：Lycium barbarum L.For plant of Solanaceae lycium barbarum Lycium barbarum
L. dry mature fruit.Purchased from the double precious Chinese medicine sale Co., Ltds of Bozhou City.
Cortex Eucommiae, Classification system：Eucommia ulmoides Oliver also known as bakelite.For the dry of Eucommiaceae plant Cortex Eucommiae
Dry bark.Purchased from Bozhou City Run Yu pharmaceutcal corporation, Ltds.
Rhizoma Atractylodis Macrocephalae, Classification system：Atractylodes macrocephala are feverfew Rhizoma Atractylodis Macrocephalae Atractylodes
The rhizome of macrocephala Koidz..Purchased from Bozhou City Song Yuantang pharmaceutcal corporation, Ltds.
Cassia twig, Classification system：CassiaTwig, also known as beautiful osmanthus.For canella Chinese cassia tree Cinnamomum cassia
The dry twig of Presl.Purchased from Bozhou City Huimin Chinese medicine wholesale house.
Sophora flower, Classification system：Sophorajaponica Linn.Flower and alabastrum for legume.Purchased from Bozhou City ten thousand
Flower hall medicine company sale Co., Ltd.
Rhizoma zingiberis is the dry rhizome of zingiber Zingiber officinale Rosc..Purchased from hundred continent of Bozhou City hall
Medicine company sells Co., Ltd.
Semen Cuscutae, Classification system：Cuscuta chinensis.Purchased from hundred continent of Bozhou City hall medicine company sale Co., Ltd.
Safflower, Classification system：Carthamus tinctorius L..For feverfew safflower Carthamus
The tubular corolla of tinctorius L..Purchased from the expensive Meikang Chinese medicine sale Co., Ltd of Bozhou City.
The fleece-flower root, Classification system：polygoni multiflori.For polygonum multiflorum thunb Fallopia
The dried root of multiflora (Thunb.) Harald..Purchased from Bozhou City Huimin Chinese medicine wholesale house.
Poria cocos, Classification system：Wolfiporia cocos.To intend the dry sclerotia of shelf fungus section fungi Poria cocos.Purchased from Bo
Run Yu pharmaceutcal corporation, Ltds of state city.
Umbellate pore furgus, Classification system：polyporus.For On Polyporaceae umbellate pore furgus (Polyporus umbellatus
(Pers.) Fries) dry sclerotia.Purchased from Bozhou City Run Yu pharmaceutcal corporation, Ltds.
Agalloch eaglewood, Classification system：Aquilariaagallocha(Lour.)Roxb.For dicotyledon medicine Thymelaeceae arbor
Plant agalloch eaglewood Aquilaria agallocha (Lour.) Roxb or white A.sinensis (Lour.) Gilg is by nature
Wound or point condensed by the grease secreted out of during self-regeneration after artificial destruction by the infection of fungi
Secretion.Purchased from city harbor city Fangcheng District great LuFu Yuan firms.
Santal, Classification system：Santalum album L..Heartwood for sandalwood plants.Have purchased from Hebei primeval atmosphere of nature perfume (or spice) industry
Limit company.
Rhizoma nardostachyos is the drying root and rhizome of patrinia herb rhizoma nardostachyos Nardostachysjatamansi DC..Purchased from Bozhou
City monarch source hall medicinal material station.
The root of Dahurain angelica, Classification system：Angelica dahurica.Purchased from the sub- safe Chinese medicine wholesale house of Bozhou City.
Cloves, Classification system：Syzygiumaromaticum.For dicotyledon plant clove of myrtaceae Eugenia
The dry flower of caryophyllata.Purchased from Bozhou City Song Yuantang pharmaceutcal corporation, Ltds.
Pectase, food-grade, purchased from Hunan Wei Xing bio tech ltd, 1,000,000,000/g of enzyme activity.
Amylase, food-grade, purchased from the Central-South bio tech ltd in Anhui, 2,000,000,000/g of enzyme activity.
Yeast, specifically using Saccharomyces cerevisiae yeast, food-grade, purchased from the huge flourish bioengineering in Shandong
Co., Ltd.
It is prepared by sandalwood tea, the specific embodiment of the patent of invention of referenced patent application number 201010154391.4.
It is prepared by Ligaloes tea, the embodiment one of the patent of invention of referenced patent application number 201210061883.8.
Roseleaf spends hall medicine company sale Co., Ltd purchased from Bozhou City ten thousand.It crushed 100 sieves before use.
Dark plum, Classification system：DarkPlumFruit specifically uses Leshan horse side dark plum.
Reverse osmosis membrane, purchased from Shenzhen gallon membrane technology Co., Ltd, model GL-800G, molecular cut off 100,000.
Honey, using the honey of various flowers purchased from Shanxi Sheng Kang apicultures Co., Ltd.
Glutamic acid, No. CAS：56-86-0, purchased from Shanghai Xi Long biochemical technologies Co., Ltd.
Embodiment 1
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, roseleaf 3wt%, surplus are incense drug；The incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, cassia twig
3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, agalloch eaglewood 3g, santal 3g, rhizoma nardostachyos 1g,
Root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
It is cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, agalloch eaglewood 3g, santal 3g, sweet
Loose 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) and expect：Incense drug, fir powder, nanmu powder, elm bark powder, roseleaf are put into blender, according to incense drug and water
Weight ratio 1：1 ratio adds in 45 DEG C of water, is stirred 20 minutes with 30 revs/min；
(4) it is molded：Material after step (3) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(5) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(6) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
Embodiment 2
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, roseleaf 3wt%, surplus are incense drug；The incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, cassia twig
3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, agalloch eaglewood 3g, santal 3g, rhizoma nardostachyos 1g,
Root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
It is cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, agalloch eaglewood 3g, santal 3g, sweet
Loose 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) it digests：The incense drug 50g of step (2) is weighed, deionized water 200mL is added in, sequentially adds incense drug weight 0.003
The amylase of 0.002 times of pectase again and incense drug weight is uniformly mixed, and is digested 2 hours in 45 DEG C；By enzymolysis liquid in boiling water bath
Middle enzyme deactivation after ten minutes, vacuum freeze drying, the incense drug after being digested；The actual conditions of vacuum freeze drying：Pre-freezing temperature-
25 DEG C, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, vacuum degree
0.096MPa；
(4) and expect：By after enzymolysis incense drug, fir powder, nanmu powder, elm bark powder, roseleaf be put into blender, according to
Incense drug and water weight ratio 1 after enzymolysis：1 ratio adds in 45 DEG C of water, is stirred 20 minutes with 30 revs/min；
(5) it is molded：Material after step (4) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(6) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(7) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
Embodiment 3
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, roseleaf 3wt%, surplus are incense drug；The incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, cassia twig
3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, agalloch eaglewood 3g, santal 3g, rhizoma nardostachyos 1g,
Root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
It is cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, agalloch eaglewood 3g, santal 3g, sweet
Loose 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) it digests：The incense drug 50g of step (2) is weighed, deionized water 200mL is added in, sequentially adds incense drug weight 0.003
The amylase of 0.002 times of pectase again and incense drug weight is uniformly mixed, and is digested 2 hours in 45 DEG C；By enzymolysis liquid in boiling water bath
Middle enzyme deactivation after ten minutes, vacuum freeze drying, the incense drug after being digested；The actual conditions of vacuum freeze drying：Pre-freezing temperature-
25 DEG C, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, vacuum degree
0.096MPa；
(4) yeast ferments：Yeast 12g is added in the sterile water of 40 DEG C of 150mL temperature, activate 2 hours, obtain in 30 DEG C
Activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：10 (g/mL) added in distilled water, in boiling water bath sterilization treatment 20 minutes；It will
Mixed liquor after sterilizing is cooled to 30 DEG C, adds in the activated yeast of 0.04 times of mixeding liquid volume, is sent out under conditions of 30 DEG C, pH5
Ferment 36 hours；By zymotic fluid vacuum freeze drying, the incense drug after yeast fermentation is obtained；The actual conditions of vacuum freeze drying：In advance
- 25 DEG C of temperature of jelly, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, very
Reciprocal of duty cycle 0.096MPa；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, roseleaf are put into blender,
Incense drug and water weight ratio 1 after fermenting according to yeast：1 ratio adds in 45 DEG C of water, is stirred 20 minutes with 30 revs/min；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
Embodiment 4
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, roseleaf 3wt%, surplus are incense drug；The incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, cassia twig
It is 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea 3g, sweet
Loose 1g, root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
Cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea
3g, rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) it digests：The incense drug 50g of step (2) is weighed, deionized water 200mL is added in, sequentially adds incense drug weight 0.003
The amylase of 0.002 times of pectase again and incense drug weight is uniformly mixed, and is digested 2 hours in 45 DEG C；By enzymolysis liquid in boiling water bath
Middle enzyme deactivation after ten minutes, vacuum freeze drying, the incense drug after being digested；The actual conditions of vacuum freeze drying：Pre-freezing temperature-
25 DEG C, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, vacuum degree
0.096MPa；
(4) yeast ferments：Yeast 12g is added in the sterile water of 40 DEG C of 150mL temperature, activate 2 hours, obtain in 30 DEG C
Activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：10 (g/mL) added in distilled water, in boiling water bath sterilization treatment 20 minutes；It will
Mixed liquor after sterilizing is cooled to 30 DEG C, adds in the activated yeast of 0.04 times of mixeding liquid volume, is sent out under conditions of 30 DEG C, pH5
Ferment 36 hours；By zymotic fluid vacuum freeze drying, the incense drug after yeast fermentation is obtained；The actual conditions of vacuum freeze drying：In advance
- 25 DEG C of temperature of jelly, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, very
Reciprocal of duty cycle 0.096MPa；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, roseleaf are put into blender,
Incense drug and water weight ratio 1 after fermenting according to yeast：1 ratio adds in 45 DEG C of water, is stirred 20 minutes with 30 revs/min；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
Embodiment 5
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, smoked plum extractive 3wt%, surplus are incense drug；The incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, osmanthus
Branch 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea 3g,
Rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
Cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea
3g, rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) it digests：The incense drug 50g of step (2) is weighed, deionized water 200mL is added in, sequentially adds incense drug weight 0.003
The amylase of 0.002 times of pectase again and incense drug weight is uniformly mixed, and is digested 2 hours in 45 DEG C；By enzymolysis liquid in boiling water bath
Middle enzyme deactivation after ten minutes, vacuum freeze drying, the incense drug after being digested；The actual conditions of vacuum freeze drying：Pre-freezing temperature-
25 DEG C, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, vacuum degree
0.096MPa；
(4) yeast ferments：Yeast 12g is added in the sterile water of 40 DEG C of 150mL temperature, activate 2 hours, obtain in 30 DEG C
Activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：10 (g/mL) added in distilled water, in boiling water bath sterilization treatment 20 minutes；It will
Mixed liquor after sterilizing is cooled to 30 DEG C, adds in the activated yeast of 0.04 times of mixeding liquid volume, is sent out under conditions of 30 DEG C, pH5
Ferment 36 hours；By zymotic fluid vacuum freeze drying, the incense drug after yeast fermentation is obtained；The actual conditions of vacuum freeze drying：In advance
- 25 DEG C of temperature of jelly, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, very
Reciprocal of duty cycle 0.096MPa；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, smoked plum extractive are put into blender
In, incense drug and water weight ratio 1 after fermenting according to yeast：1 ratio adds in 45 DEG C of water, is stirred 20 minutes with 30 revs/min；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
The preparation method of the smoked plum extractive is：By the dark plum of naturally dry, after crushed 60 mesh sieve, with solid-liquid ratio 1：
10 (g/mL) are added in the ethyl alcohol of volume fraction 95%, are extracted 5 hours in 70 DEG C, are obtained extracting solution；By extracting solution with 4000 turns/
After minute centrifugation 15 minutes, supernatant liquor is taken；By supernatant liquor in 40 DEG C of temperature, pressure 35 standard atmospheric pressure, flow velocity 3m/s
Under the conditions of using reverse osmosis membrane concentrate, obtain concentrate；By concentrate vacuum freeze drying, the smoked plum extractive is obtained.Very
The actual conditions of vacuum freecing-dry：- 25 DEG C of pre-freezing temperature, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, very
18 hours vacuum freecing-dry time, vacuum degree 0.096MPa.
Embodiment 6
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, honey reactant 3wt%, surplus is incense drug；The incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, osmanthus
Branch 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea 3g,
Rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
Cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea
3g, rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) it digests：The incense drug 50g of step (2) is weighed, deionized water 200mL is added in, sequentially adds incense drug weight 0.003
The amylase of 0.002 times of pectase again and incense drug weight is uniformly mixed, and is digested 2 hours in 45 DEG C；By enzymolysis liquid in boiling water bath
Middle enzyme deactivation after ten minutes, vacuum freeze drying, the incense drug after being digested；The actual conditions of vacuum freeze drying：Pre-freezing temperature-
25 DEG C, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, vacuum degree
0.096MPa；
(4) yeast ferments：Yeast 12g is added in the sterile water of 40 DEG C of 150mL temperature, activate 2 hours, obtain in 30 DEG C
Activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：10 (g/mL) added in distilled water, in boiling water bath sterilization treatment 20 minutes；It will
Mixed liquor after sterilizing is cooled to 30 DEG C, adds in the activated yeast of 0.04 times of mixeding liquid volume, is sent out under conditions of 30 DEG C, pH5
Ferment 36 hours；By zymotic fluid vacuum freeze drying, the incense drug after yeast fermentation is obtained；The actual conditions of vacuum freeze drying：In advance
- 25 DEG C of temperature of jelly, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, very
Reciprocal of duty cycle 0.096MPa；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, honey reactant are put into blender
In, incense drug and water weight ratio 1 after fermenting according to yeast：1 ratio adds in 45 DEG C of water, is stirred 20 minutes with 30 revs/min；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
The preparation process of the honey reactant is：0.5g glutamic acid and 1.2g honey are uniformly mixed, add in 15mL third
Glycol is heated to 110 DEG C and reacts 3 hours；After reaction, reaction solution is cooled to 20 DEG C, in 40 DEG C, vacuum degree 0.07MPa
Under conditions of dry 12 hours, obtain the honey reactant.
Embodiment 7
Renal function conditioning medication is fragrant, is prepared including following raw material：Fir powder 3wt%, nanmu powder 1wt%, elm bark powder
2wt%, honey reactant 1.5wt%, smoked plum extractive 1.5wt%, surplus is incense drug；The incense drug raw material proportioning is：Matrimony vine
Sub- 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g, cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus
2g, Ligaloes tea 3g, sandalwood tea 3g, rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g.
The processing technology of above-mentioned renal function conditioning medication perfume, includes the following steps：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：Fruit of Chinese wolfberry 3g, Cortex Eucommiae 3g, Rhizoma Atractylodis Macrocephalae 3g,
Cassia twig 3g, sophora flower 2g, rhizoma zingiberis 4g, Semen Cuscutae 3g, safflower 2g, fleece-flower root 3g, Poria cocos 4g, umbellate pore furgus 2g, Ligaloes tea 3g, sandalwood tea
3g, rhizoma nardostachyos 1g, root of Dahurain angelica 1g, cloves 1g；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and mixing
Powder mixing, obtains incense drug；
(3) it digests：The incense drug 50g of step (2) is weighed, deionized water 200mL is added in, sequentially adds incense drug weight 0.003
The amylase of 0.002 times of pectase again and incense drug weight is uniformly mixed, and is digested 2 hours in 45 DEG C；By enzymolysis liquid in boiling water bath
Middle enzyme deactivation after ten minutes, vacuum freeze drying, the incense drug after being digested；The actual conditions of vacuum freeze drying：Pre-freezing temperature-
25 DEG C, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, vacuum degree
0.096MPa；
(4) yeast ferments：Yeast 12g is added in the sterile water of 40 DEG C of 150mL temperature, activate 2 hours, obtain in 30 DEG C
Activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：10 (g/mL) added in distilled water, in boiling water bath sterilization treatment 20 minutes；It will
Mixed liquor after sterilizing is cooled to 30 DEG C, adds in the activated yeast of 0.04 times of mixeding liquid volume, is sent out under conditions of 30 DEG C, pH5
Ferment 36 hours；By zymotic fluid vacuum freeze drying, the incense drug after yeast fermentation is obtained；The actual conditions of vacuum freeze drying：In advance
- 25 DEG C of temperature of jelly, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, 18 hours vacuum freeze drying time, very
Reciprocal of duty cycle 0.096MPa；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, honey reactant, smoked plum extractive
It is put into blender, the incense drug after fermenting according to yeast and water weight ratio 1：1 ratio adds in 45 DEG C of water, with 30 revs/min
Stirring 20 minutes；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into extruder
Hopper in, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15 DEG C of temperature, relative humidity 70% environment in store sth. in a cellar 7
My god.
The preparation method of the smoked plum extractive is：By the dark plum of naturally dry, after crushed 60 mesh sieve, with solid-liquid ratio 1：
10 (g/mL) are added in the ethyl alcohol of volume fraction 95%, are extracted 5 hours in 70 DEG C, are obtained extracting solution；By extracting solution with 4000 turns/
After minute centrifugation 15 minutes, supernatant liquor is taken；By supernatant liquor in 40 DEG C of temperature, pressure 35 standard atmospheric pressure, flow velocity 3m/s
Under the conditions of using reverse osmosis membrane concentrate, obtain concentrate；By concentrate vacuum freeze drying, the smoked plum extractive is obtained.Very
The actual conditions of vacuum freecing-dry：- 25 DEG C of pre-freezing temperature, pre-freeze time 2 h, 15 DEG C of sublimation temperature, 25 DEG C of resolution temperature, very
18 hours vacuum freecing-dry time, vacuum degree 0.096MPa.
The preparation process of the honey reactant is：0.5g glutamic acid and 1.2g honey are uniformly mixed, add in 15mL third
Glycol is heated to 110 DEG C and reacts 3 hours；After reaction, reaction solution is cooled to 20 DEG C, in 40 DEG C, vacuum degree 0.07MPa
Under conditions of dry 12 hours, obtain the honey reactant.
Test case 1
Patients with chronic renal failure 210 is selected, patient is randomly divided into 7 groups, age, gender aspect pass through patient before the treatment
Statistical procedures are crossed without apparent significant difference, are comparable (P ＞ 0.05).
Patient meets claimed below：
(1) age 18 years old~65 years old；
(2) non-pregnant or women breast-feeding their children, non-allergic constitution person；
(3) not serious cardiovascular and cerebrovascular, liver and disease of hematopoietic system or mental patient；
(4) dialysis therapy is not used before treatment and in treatment, using hormone and immunosuppressant treatment.
(5) compliance is good.
Therapy：Every group on the basis of diet control and doctor trained in Western medicine symptomatic treatment, every afternoon is in 20m3It is closed
The renal function conditioning medication perfume (or spice) 1.5g of embodiment 1-7, patient's smelling, until medicine perfume (or spice) after-flame, the course for the treatment of 3 are lighted in room respectively
Month.
(1) clinical symptoms of patient integration is counted, the results are shown in Table 1.Statistical analysis is carried out after each group,
The result shows that P ＜ 0.05, difference has statistical significance.
Clinical symptoms ranking criterion is as follows：
Lassitude：Nothing, 0 point；Degree is slight, can adhere to light physical labor, 1 point；General activity feels weak, exerts oneself
Strong support daily routines, 2 points；Fatigue and weak is also felt in rest, it is impossible to adhere to daily routines, 3 points.
Soreness and weakness of waist and knees：Nothing, 0 point；Soreness and weakness of waist and knees from morning, beating can alleviate, 1 point；Soreness and weakness of waist and knees, lower limb are heavy, and 2
Point；Soreness and weakness of waist and knees is difficult to endure, it is impossible to it walks, 3 points.
Shortness of breath lazyness is sayed：Nothing, 0 point；Short wind, words of speaking more feel tired, 1 point；Physically weak shortness of breath, is disinclined to speech, 2 points；It says
Talk about that sound is humble and intermittent or powerless speech, 3 points.
Nausea and vomiting：Nothing, 0 point；Daily nausea and vomiting 1~2 time, 1 point；Daily nausea and vomiting 3~4 times, 2 points；Again and again it vomits
Spit, 4 times a day more than, 3 points.
Deficiency of food is indigestion and loss of appetite：Nothing, 0 point；Appetite is not good enough, and taste is not fragrant, and appetite, which is reduced, is no more than a quarter, 1 point；Appetite is not
It shakes, taste is not fragrant, appetite reduction a quarter to half, 2 points；Appetite is excessively poor, no hunger, and appetite reduction two/
More than one, 3 points.
Dim complexion：Nothing, 0 point；Complexion is dark yellow and lacks gloss, 1 point；Complexion is dark yellow and matt, 2 points；Complexion it is black dull and
Tarnish, 3 points.
Table 1：The clinical symptoms table of integrals
| Clinical symptoms integrate | |
| Embodiment 1 | 12 points |
| Embodiment 2 | 11 points |
| Embodiment 3 | 9 points |
| Embodiment 4 | 8 points |
Patient generates over the course for the treatment of without adverse reaction, and safety of the present invention is affirmed.Before patient's treatment
After compare, be respectively provided with significant difference (P<0.01).Wherein, embodiment 2~4 is better than in terms of TCM symptom score is improved
1 (P of embodiment<0.05).
(2) serum creatinine of patient and urea nitrogen are tested, the results are shown in Table 2.
Table 2：Renal function index result table
From table 2 it can be seen that embodiment 2~3, compared to embodiment 1, patient's serum creatinine and urea nitrogen are on a declining curve
(P<0.05)。
Test case 2
After the renal function conditioning medication perfume (or spice) of embodiment 1-7 is balanced 24 hours under conditions of 25 DEG C of constant temperature, constant humidity 65%,
Smelling marking is carried out for 4 fragrance, harmony, miscellaneous gas, stimulation indexs by 10 professionals, is averaged.Highest is divided into
5, it is minimum to be divided into 0.Statistical analysis is carried out after each group, the results showed that P ＜ 0.05, difference have statistical significance.As a result
It is shown in Table 3.
Table 3：Sensory evaluation scores test result table
Test case 3
The air sterilization effect of the renal function conditioning medication perfume of embodiment 1-7 is tested, the results are shown in Table 4.
Foundation《Disinfection technology standard》(2002 editions) 2.1.3.5 select volume 20m3Unmanned room carries out on-the-spot disinfection
Experiment, carry out disinfection in closed room before air natural bacteria sample 5 minutes, as being compareed before disinfection.Light indoors 3 it is single
The linear medicine of weight 0.4g is fragrant, and after sterilizing 2 hours, indoor Confucius's natural bacteria samples 5 minutes.Sampling ware is cultivated 5 minutes in 37 DEG C,
Clump count is observed, calculates natural bacteria extinction rate.
Table 4：Air sterilization effect table
The foregoing is merely presently preferred embodiments of the present invention, all equivalent changes done according to scope of the present invention patent with
Modification should all belong to the covering scope of the present invention.
Claims (9)
1. a kind of renal function conditioning medication is fragrant, which is characterized in that is prepared including following raw material：2~5wt% of fir powder, nanmu
0.4~2wt% of wood powder, 1~3wt% of elm bark powder, additivity 1~3wt% of material, surplus is incense drug；The incense drug includes matrimony vine
Son, Cortex Eucommiae, Rhizoma Atractylodis Macrocephalae, cassia twig, sophora flower, rhizoma zingiberis, Semen Cuscutae, safflower, the fleece-flower root, Poria cocos, umbellate pore furgus, agalloch eaglewood or Ligaloes tea, santal
Or sandalwood tea, rhizoma nardostachyos, the root of Dahurain angelica, cloves.
2. renal function as described in claim 1 conditioning medication is fragrant, which is characterized in that the incense drug raw material proportioning is：The fruit of Chinese wolfberry 1
~3g, 1~3g of Cortex Eucommiae, 1~3g of Rhizoma Atractylodis Macrocephalae, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower,
3~4g of the fleece-flower root, 3~4g of Poria cocos, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, rhizoma nardostachyos
0.1~1g, 0.1~1g of the root of Dahurain angelica, 0.5~1g of cloves.
3. renal function conditioning medication according to claim 1 is fragrant, which is characterized in that the additivity material is petal, crow
The mixture of one or more of prunus mume extract, honey reactant.
4. renal function conditioning medication according to claim 3 is fragrant, which is characterized in that the preparation method of the smoked plum extractive
For：By the dark plum of naturally dry, after crushed 40~60 mesh sieve, with solid-liquid ratio 1：(10~20) (g/mL) adds in volume fraction
In 95% ethyl alcohol, extracted 2~5 hours in 70~80 DEG C, obtain extracting solution；By extracting solution with 4000~5000 revs/min from
After the heart 10~15 minutes, supernatant liquor is taken；By supernatant liquor in 20~65 DEG C of temperature, 20~35 standard atmospheric pressure of pressure, flow velocity 2
It is concentrated under conditions of~3m/s using reverse osmosis membrane, obtains concentrate；By concentrate vacuum freeze drying, obtain the dark plum and carry
Take object.
5. renal function conditioning medication according to claim 3 is fragrant, which is characterized in that the preparation process of the honey reactant
For：0.3~0.5g amino acid and 1~2g honey are uniformly mixed, add in 10~15mL propylene glycol, is heated to 110~120 DEG C instead
It answers 2~3 hours；After reaction, reaction solution is cooled to 20~30 DEG C, vacuum drying obtains the honey reactant.
6. renal function conditioning medication according to claim 5 is fragrant, which is characterized in that the amino acid is tyrosine, figured silk fabrics ammonia
The mixture of one or more of acid, aspartic acid, asparagine acid, glutamic acid.
7. as described in any one of claim 1-6 renal function conditioning medication perfume processing technology, which is characterized in that including with
Lower step：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae, Rhizoma Atractylodis Macrocephalae 1
~3g, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, Poria cocos 3~
4g, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, 0.1~1g of the root of Dahurain angelica,
0.5~1g of cloves；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80~100 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80~100 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and
Mixed powder mixing, obtains incense drug；
(3) and expect：Incense drug, fir powder, nanmu powder, elm bark powder, additivity material are put into blender, according to incense drug and water weight
Measure ratio 1：The ratio of (1~1.5) adds in 40~50 DEG C of water, is stirred 20~30 minutes with 20~40 revs/min；
(4) it is molded：Material after step (3) is stirred is put into cuber, is pressed into material block, material block is put into the material of extruder
In slot, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(5) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(6) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15~20 DEG C of temperature, relative humidity 70~80% environment in
Store sth. in a cellar 7~60 days.
8. as described in any one of claim 1-6 renal function conditioning medication perfume processing technology, which is characterized in that including with
Lower step：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae, Rhizoma Atractylodis Macrocephalae 1
~3g, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, Poria cocos 3~
4g, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, 0.1~1g of the root of Dahurain angelica,
0.5~1g of cloves；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80~100 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80~100 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and
Mixed powder mixing, obtains incense drug；
(3) it digests：30~50g of incense drug of step (2) is weighed, 140~200mL of deionized water is added in, sequentially adds incense drug weight
0.001~0.003 times of pectase and the amylase of 0.001~0.003 times of incense drug weight are uniformly mixed, in 40~45 DEG C of enzymes
Solution 2~3 hours；The enzyme deactivation 5~after ten minutes in boiling water bath, vacuum freeze drying, the incense drug after being digested by enzymolysis liquid；
(4) and expect：By after enzymolysis incense drug, fir powder, nanmu powder, elm bark powder, additivity material be put into blender, according to enzyme
Incense drug and water weight ratio 1 after solution：The ratio of (1~1.5) adds in 40~50 DEG C of water, with 20~40 revs/min of stirrings 20~
30 minutes；
(5) it is molded：Material after step (4) is stirred is put into cuber, is pressed into material block, material block is put into the material of extruder
In slot, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(6) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(7) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15~20 DEG C of temperature, relative humidity 70~80% environment in
Store sth. in a cellar 7~60 days.
9. as described in any one of claim 1-6 renal function conditioning medication perfume processing technology, which is characterized in that including with
Lower step：
(1) it makes up a prescription：Incense drug raw material is weighed by formula, the incense drug raw material proportioning is：1~3g of the fruit of Chinese wolfberry, 1~3g of Cortex Eucommiae, Rhizoma Atractylodis Macrocephalae 1
~3g, 1~3g of cassia twig, 1~3g of sophora flower, 2~4g of rhizoma zingiberis, 3~5g of Semen Cuscutae, 1~2g of safflower, 3~4g of the fleece-flower root, Poria cocos 3~
4g, 1~3g of umbellate pore furgus, agalloch eaglewood either 1~3g of 1~3g of Ligaloes tea, santal or sandalwood tea, 0.1~1g of rhizoma nardostachyos, 0.1~1g of the root of Dahurain angelica,
0.5~1g of cloves；
(2) it grinds：By other incense drug raw material mixings in step (1) other than Cortex Eucommiae, cassia twig, 80~100 sieves are crushed, are obtained
To mixed powder；Cortex Eucommiae, cassia twig are crushed respectively, 80~100 sieves is crossed, obtains Cortex Eucommiae powder and cassia twig powder；By Cortex Eucommiae powder, cassia twig powder and
Mixed powder mixing, obtains incense drug；
(3) it digests：30~50g of incense drug of step (2) is weighed, 140~200mL of deionized water is added in, sequentially adds incense drug weight
0.001~0.003 times of pectase and the amylase of 0.001~0.003 times of incense drug weight are uniformly mixed, in 40~45 DEG C of enzymes
Solution 2~3 hours；The enzyme deactivation 5~after ten minutes in boiling water bath, vacuum freeze drying, the incense drug after being digested by enzymolysis liquid；
(4) yeast ferments：10~20g of yeast is added in the sterile water of 35~40 DEG C of 100~150mL temperature, in 30~32 DEG C
Activation 1~2 hour, obtains activated yeast；By the incense drug after enzymolysis with solid-liquid ratio 1：(10~12) (g/mL) adds in distilled water, in
Boiling water bath sterilization treatment 20~30 minutes；Mixed liquor after sterilizing is cooled to 30~35 DEG C, add in mixeding liquid volume 0.03~
0.06 activated yeast ferments 30~48 hours under conditions of 30~35 DEG C, pH5~6；By zymotic fluid vacuum freeze drying,
Obtain the incense drug after yeast fermentation；
(5) and expect：Incense drug, fir powder, nanmu powder after yeast is fermented, elm bark powder, additivity material are put into blender, are pressed
Incense drug and water weight ratio 1 after fermenting according to yeast：The ratio of (1~1.5) adds in 40~50 DEG C of water, with 20~40 revs/min
Stirring 20~30 minutes；
(6) it is molded：Material after step (5) is stirred is put into cuber, is pressed into material block, material block is put into the material of extruder
In slot, raw material picks out fragrant item by being extruded in the hole of mold, with smooth fragrant square-bottomed bamboo basket；
(7) it dries：Perfume square-bottomed bamboo basket is stably placed on yoke, in the soft outdoor drying of sunlight, until fragrant item dries；
(8) packaging is stored sth. in a cellar：By after drying fragrant item packaging after, in 15~20 DEG C of temperature, relative humidity 70~80% environment in
Store sth. in a cellar 7~60 days.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810111217.8A CN108159380A (en) | 2018-02-05 | 2018-02-05 | Renal function conditioning medication perfume and its processing technology |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810111217.8A CN108159380A (en) | 2018-02-05 | 2018-02-05 | Renal function conditioning medication perfume and its processing technology |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108159380A true CN108159380A (en) | 2018-06-15 |
Family
ID=62512718
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810111217.8A Pending CN108159380A (en) | 2018-02-05 | 2018-02-05 | Renal function conditioning medication perfume and its processing technology |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108159380A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111388619A (en) * | 2020-04-13 | 2020-07-10 | 重庆桢楠中药研究所有限公司 | Traditional Chinese medicine of phyllostachys pubescens and preparation method thereof |
-
2018
- 2018-02-05 CN CN201810111217.8A patent/CN108159380A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111388619A (en) * | 2020-04-13 | 2020-07-10 | 重庆桢楠中药研究所有限公司 | Traditional Chinese medicine of phyllostachys pubescens and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR101332321B1 (en) | Health food fermented using effective micro-organisms with herbal medicine and manufacturing method thereof | |
| CN113143812B (en) | Preparation method of kava pepper fermentation product, kava pepper fermentation product and application of kava pepper fermentation product in cosmetics | |
| CN113278535B (en) | New strain ZL167 of ganoderma lucidum and new application thereof | |
| KR101431417B1 (en) | The method of oriental composite for treatment of atopy and cancer | |
| CN107057917A (en) | Hydromel and preparation method thereof | |
| CN107233244A (en) | A kind of preparation method and applications of Sanqi fermentation liquor | |
| CN106720685A (en) | A kind of blue or green money willow instant tea and preparation method thereof | |
| CN110564570A (en) | agilawood-flavor liquor formula and method | |
| CN108159380A (en) | Renal function conditioning medication perfume and its processing technology | |
| CN106389788A (en) | Medicine extract for strengthening anti-virus capability and immune function of livestock, preparation, and preparation method | |
| CN107823026A (en) | A kind of fermentation and its is preparing the application of skin whitening, moisturizing skin care item at compound | |
| Chavalittumrong et al. | Chronic toxicity study of Portulaca grandiflora Hook | |
| WO2021142920A1 (en) | Traditional chinese medicine composition for treating lung cancer, and preparation and use thereof | |
| KR102070507B1 (en) | Manufacturing method for samgyetang using black ginseng and samgyetang using black ginseng manufactured by the same | |
| CN108685951B (en) | A kind of stingless bee Mel extract and its extracting method and application | |
| KR101126095B1 (en) | Method for manufacturing functional jujube using bioprocess and functional jujube | |
| KR101145498B1 (en) | Method for manufacturing bodywash and bodywash composition thereof containing natural oriental plant extracts | |
| CN101185616A (en) | Face pack and preparation method thereof | |
| CN102827740A (en) | Baisui (Chinese character) wine and preparation method thereof | |
| KR20190086096A (en) | Medicinal herbs composition for improving cognitive function | |
| CN108142790A (en) | Mental-tranquilization wheat flour | |
| KR20230018906A (en) | Composition for Bone Growth Promoting comprising Complex Extract of Cyanchum wilfordii and Phlomis umbrosa and Health Functional Food containing the same | |
| CN110804518A (en) | Preparation method of jasmine flower wine | |
| CN108968031A (en) | The antitumor row liver poison Wild ganoderma product of anticancer and technology of preparing | |
| CN115337350B (en) | Composition preparation with kidney-strengthening and yang-supporting effects and preparation method and application thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180615 |